The HER (human epidermal growth factor receptor) family, comprising EGFR/HER1, HER2, ErbB3/HER3, and ErbB4/HER4, plays a pivotal role in GC through ligand-independent homodimerization and subsequent activation of oncogenic signaling pathways [5]. This evidence concerns the gene ERBB4 and gastric cancer.